QV Bioelectronics raises £4.5m to transform glioblastoma treatment with a world-first implantable device, aiming to improve patient outcomes.
Amount Raised
£4.5 Million
Round Type
Funding Round
ManchesterDescription
QV Bioelectronics has secured £4.5 million in investment and grant funding to develop a groundbreaking treatment for glioblastoma (GBM). The funding will support ongoing clinical trial work, leading to a first-in-human study planned for mid-2026. The company focuses on delivering electric field therapy to enhance survival rates for GBM patients. This innovative approach aims to provide better treatment options for a disease with a high recurrence rate.
Who to call at Qv Bioelectronics, and when
A new round usually means Qv Bioelectronics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Qv Bioelectronics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Qv Bioelectronics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Qv Bioelectronics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Qv Bioelectronics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Qv Bioelectronics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.